Clinical Trial: Study of MP0533 in Patients Acute Myeloid Leukemia or Myelodysplastic Syndrome
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition:
Leukemia
Myeloid
Acute
Newly Diagnosed
Study Type: INTERVENTIONAL
Official Title: A Phase 1/2a, First-in-human, Open-label, Multicenter, Dose Escalation Study of MP0533 in Patients With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
Brief Summary:
The purpose of this study is to evaluate the safety, tolerability, and preliminary activity of MP0533 in patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS)
Read more